News
Article
Pharmaceutical Technology
Pharmaceutical Technology-05-15-2014Volume2014 eBook Issue 2
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
Author(s):
A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.
A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.
Download
Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook.
Articles in this issue
Potential Benefits Drive Interest in Continuous Manufacturing
Continuous Bioprocessing Challenges
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
Achieving and Maintaining Compliance Using Continuous Monitoring Systems
Optimizing the Sterilization of Liquids in Sealed Containers
Using Modular Systems in Biopharmaceutical Manufacturing
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
